Dow Up0.66% Nasdaq Up0.88%

Sangamo Biosciences Inc. (SGMO)

-NasdaqGS
6.48 Up 0.18(2.86%) May 2, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Total Revenue 9,121   8,569   8,358   13,491  
Cost of Revenue -   -   -   -  
Gross Profit 9,121   8,569   8,358   13,491  
Operating Expenses
Research Development19,906  16,694  15,618  14,980  
Selling General and Administrative4,888  4,560  5,017  4,732  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (15,673) (12,685) (12,277) (6,221)
Income from Continuing Operations
Total Other Income/Expenses Net25  101  151  154  
Earnings Before Interest And Taxes(15,648)(12,584)(12,126)(6,067)
Interest Expense -   -   -   -  
Income Before Tax(15,648)(12,584)(12,126)(6,067)
Income Tax Expense(1,635)(3,339) -  (748)
Minority Interest -   -   -   -  
Net Income From Continuing Ops(14,013)(9,245)(12,126)(5,319)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (14,013) (9,245) (12,126) (5,319)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (14,013) (9,245) (12,126) (5,319)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.